272 related articles for article (PubMed ID: 11331750)
1. Glutamate antagonists limit tumor growth.
Rzeski W; Turski L; Ikonomidou C
Proc Natl Acad Sci U S A; 2001 May; 98(11):6372-7. PubMed ID: 11331750
[TBL] [Abstract][Full Text] [Related]
2. Glutamate antagonists limit tumor growth.
Rzeski W; Ikonomidou C; Turski L
Biochem Pharmacol; 2002 Oct; 64(8):1195-200. PubMed ID: 12234599
[TBL] [Abstract][Full Text] [Related]
3. Glutamate antagonists: deadly liaisons with cancer.
Cavalheiro EA; Olney JW
Proc Natl Acad Sci U S A; 2001 May; 98(11):5947-8. PubMed ID: 11371628
[No Abstract] [Full Text] [Related]
4. Neuropeptide Y release from cultured hippocampal neurons: stimulation by glutamate acting at N-methyl-D-aspartate and AMPA receptors.
Gemignani A; Marchese S; Fontana G; Raiteri M
Neuroscience; 1997 Nov; 81(1):23-31. PubMed ID: 9300398
[TBL] [Abstract][Full Text] [Related]
5. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous blockade of two glutamate receptor subtypes (NMDA and AMPA) results in stressor-specific inhibition of prolactin and corticotropin release.
Zelena D; Makara GB; Jezova D
Neuroendocrinology; 1999 May; 69(5):316-23. PubMed ID: 10343172
[TBL] [Abstract][Full Text] [Related]
7. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats.
Kenny PJ; Gasparini F; Markou A
J Pharmacol Exp Ther; 2003 Sep; 306(3):1068-76. PubMed ID: 12805481
[TBL] [Abstract][Full Text] [Related]
8. NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth.
Stepulak A; Sifringer M; Rzeski W; Endesfelder S; Gratopp A; Pohl EE; Bittigau P; Felderhoff-Mueser U; Kaindl AM; Bührer C; Hansen HH; Stryjecka-Zimmer M; Turski L; Ikonomidou C
Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15605-10. PubMed ID: 16230611
[TBL] [Abstract][Full Text] [Related]
9. Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury?
Prehn JH; Lippert K; Krieglstein J
Eur J Pharmacol; 1995 Jan; 292(2):179-89. PubMed ID: 7720791
[TBL] [Abstract][Full Text] [Related]
10. Blocking glutamate-mediated signalling inhibits human melanoma growth and migration.
Song Z; He CD; Liu J; Sun C; Lu P; Li L; Gao L; Zhang Y; Xu Y; Shan L; Liu Y; Zou W; Zhang Y; Gao H; Gao W
Exp Dermatol; 2012 Dec; 21(12):926-31. PubMed ID: 23171453
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological and molecular characterization of glutamate receptors in the MIN6 pancreatic beta-cell line.
Morley P; MacLean S; Gendron TF; Small DL; Tremblay R; Durkin JP; Mealing G
Neurol Res; 2000 Jun; 22(4):379-85. PubMed ID: 10874687
[TBL] [Abstract][Full Text] [Related]
12. Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats.
Bubser M; Tzschentke T; Hauber W
J Neural Transm Gen Sect; 1995; 101(1-3):115-26. PubMed ID: 8695042
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and 6-nitro-7-sulphamoylbenzo(f)quinoxaline-2,3-dione in the rat basal ganglia: calcification, changes in glutamate receptors and glial reactions.
Petegnief V; Saura J; Dewar D; Cummins DJ; Dragunow M; Mahy N
Neuroscience; 1999; 94(1):105-15. PubMed ID: 10613501
[TBL] [Abstract][Full Text] [Related]
14. Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK-801) injures pyramidal neurons in rat retrosplenial cortex.
Tomitaka S; Tomitaka M; Tolliver BK; Sharp FR
Eur J Neurosci; 2000 Apr; 12(4):1420-30. PubMed ID: 10762370
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the glutamate receptors mediating release of somatostatin from cultured hippocampal neurons.
Fontana G; De Bernardi R; Ferro F; Gemignani A; Raiteri M
J Neurochem; 1996 Jan; 66(1):161-8. PubMed ID: 8522949
[TBL] [Abstract][Full Text] [Related]
16. Deramciclane inhibits N-methyl-D-aspartate receptor function.
Kovács I; Szárics E; Skuban N; Kardos J
Brain Res Bull; 2000 May; 52(1):39-44. PubMed ID: 10779701
[TBL] [Abstract][Full Text] [Related]
17. Domoic acid neurotoxicity in cultured cerebellar granule neurons is mediated predominantly by NMDA receptors that are activated as a consequence of excitatory amino acid release.
Berman FW; Murray TF
J Neurochem; 1997 Aug; 69(2):693-703. PubMed ID: 9231729
[TBL] [Abstract][Full Text] [Related]
18. Excitotoxic death induced by released glutamate in depolarized primary cultures of mouse cerebellar granule cells is dependent on GABAA receptors and niflumic acid-sensitive chloride channels.
Babot Z; Cristòfol R; Suñol C
Eur J Neurosci; 2005 Jan; 21(1):103-12. PubMed ID: 15654847
[TBL] [Abstract][Full Text] [Related]
19. Na(+)-K(+)-ATPase inhibition and depolarization induce glutamate release via reverse Na(+)-dependent transport in spinal cord white matter.
Li S; Stys PK
Neuroscience; 2001; 107(4):675-83. PubMed ID: 11720790
[TBL] [Abstract][Full Text] [Related]
20. AMPA antagonists inhibit the extracellular signal regulated kinase pathway and suppress lung cancer growth.
Stepulak A; Sifringer M; Rzeski W; Brocke K; Gratopp A; Pohl EE; Turski L; Ikonomidou C
Cancer Biol Ther; 2007 Dec; 6(12):1908-15. PubMed ID: 18059166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
